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Abstract 
Global efforts to combat the Covid-19 pandemic caused by the beta coronavirus SARS-CoV-2 are 
currently based on RT-qPCR-based diagnostic tests. However, their high cost, moderate throughput 
and reliance on sophisticated equipment limit widespread implementation. Loop-mediated 
isothermal amplification after reverse transcription (RT-LAMP) is an alternative detection method 
that has the potential to overcome these limitations. Here we present a rapid, robust, highly 
sensitive and versatile RT-LAMP based SARS-CoV-2 detection assay. Our forty-minute procedure 
bypasses a dedicated RNA isolation step, is insensitive to carry-over contamination, and uses a 
hydroxynaphthol blue (HNB)-based colorimetric readout, which allows robust SARS-CoV-2 
detection from various sample types. Based on this assay we have substantially increased sensitivity 
and scalability by a simple nucleic acid enrichment step (bead-LAMP), established a pipette-free 
version for home testing (HomeDip-LAMP), and developed a version with open source enzymes 
that could be produced in any molecular biology setting. Our advanced, universally applicable RT-
LAMP assay is a major step towards population-scale SARS-CoV-2 testing. 
Keywords: Covid-19 diagnostics, RT-LAMP, Coronavirus, SARS-CoV-2, isothermal amplification, open-source 
  
Introduction 
 The Covid-19 pandemic poses unprecedented 
global health and economic challenges. The underlying 
Coronavirus Disease 2019 (Covid-19) is caused by 
infection with the single-stranded, positive-sense RNA 
beta-coronavirus SARS-CoV-2 (Gorbalenya et al., 
2020). In the absence of effective treatment or vaccines, 
efforts to contain the spread of SARS-CoV-2 rely on 
systematic viral testing, contact tracing and isolation of 
infected individuals (Ferretti et al., 2020). Since SARS-
CoV-2 carriers can be asymptomatic despite being 
infectious, a key challenge is to develop affordable and 
scalable technologies that enable population-wide 
testing (L. Zou et al., 2020). The gold-standard 
technique to detect an acute SARS-CoV-2 infection 
relies on nucleic acid diagnostics by RT-qPCR, which 
has been the method of choice due to its large dynamic 
range and high specificity (Corman et al., 2020). 
However, the need for specialized equipment and 
associated high cost make this technology unsuitable for 
population-scale testing, low resource settings and home 
testing. Moreover, slow turn-around times of several 
hours limit the applicability of RT-qPCR-based testing 
for situations where rapid screening is needed (CDC, 
2020).  
 Isothermal nucleic acid amplification techniques, 
such as RPA (Recombinase-based Polymerase 
Amplification) (Piepenburg, Williams, Stemple, & 
Armes, 2006) or LAMP (Loop mediated isothermal 
amplification) (Notomi et al., 2000), have great 
potential to fill the technological gap required for large 
scale testing strategies as they enable rapid nucleic acid 
diagnostics with minimal equipment requirement 
(Niemz, Ferguson, & Boyle, 2011). Coupled to a reverse 
transcriptase step that converts viral RNA into single 
stranded DNA, several LAMP protocols for SARS-
CoV-2 detection have been developed and applied to 
patient testing (Anahtar et al., 2020; Butler et al., 2020; 
Rabe & Cepko, 2020). Innovations such as a 
colorimetric read-out or the combination of RT-LAMP 
with specific CRISPR-Cas enzymatic detection has 
further simplified the assay and enhanced specificity, 
respectively (Zhang, Ren, et al., 2020; Broughton et al., 
2020). However, several challenges remain, especially 
in terms of assay robustness, compatibility with crude 
patient samples, limitations in sensitivity, compatibility 
with home testing setups, and access to the patent-
protected gold-standard RT-LAMP enzymes, which 
poses a central bottleneck for low-income countries.  
 Here, we present a highly versatile RT-LAMP assay 
that overcomes the afore mentioned limitations of 
current isothermal SARS-CoV-2 detection methods. We 
adopted an approach to greatly reduce the risk of carry-
over contamination for SARS-CoV-2 testing, increased 
the robustness of the assay across all tested sample types 
and buffer conditions by using hydroxynaphthol blue 
(HNB) as colorimetric readout, boosted sensitivity by at 
least ten-fold by combining RT-LAMP with a simple 
RNA enrichment procedure, benchmarked a pipette-free 
method that enables sensitive and specific detection of 
SARS-CoV-2 in home settings, and finally present a 
powerful RT-LAMP assay that builds exclusively on 
open-source enzymes.  
Results 
A rapid, sensitive and specific RT-LAMP setup for 
SARS-CoV-2 detection 
 SARS-CoV-2 diagnostics relies on detection of 
viral RNA through reverse transcription and subsequent 
amplification of small parts of the 30 kilobase viral 
genome. Considering that in SARS-CoV-2 infected 
human cells the various subgenomic viral RNAs are 
expressed at different levels (Kim et al., 2020), we 
benchmarked six published SARS-CoV-2 specific 
primer sets (see Materials and Methods) based on their 
reported high sensitivities targeting different regions of 
the viral genome: the 5'-located ORF1ab gene, the 
envelope E gene and the most 3'-located N gene 
encoding the nucleocapsid protein (Figure 1A) 
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(Broughton et al., 2020; Rabe & Cepko, 2020; Zhang, 
Odiwuor, et al., 2020; Zhang, Ren, et al., 2020). We 
used RNA extracted from nasopharyngeal swabs 
obtained from Covid-19 patients or confirmed SARS-
CoV-2 negative individuals (negative controls) and a 
SARS-CoV-2 RNA standard to determine primer 
specificity and sensitivity in RT-LAMP reactions with 
fluorometric real-time readout. None of the six primer 
sets resulted in non-specific amplification within the 
first 50 minutes in negative controls. In contrast, when 
using patient RNA or synthetic SARS-CoV-2 standard 
as input, robust target amplification occurred after 10-20 
minutes (Figure 1B, S1A, B). We conclude that RT-
LAMP alone, without additional detection steps, is 
highly specific in complex human RNA samples. 
Throughout this study, we therefore recorded 
fluorescent real-time measurements or performed end-
point analyses after 30-35 minutes reaction time.  
 Three primer sets enabled SARS-CoV-2 detection 
down to ~16 copies per reaction (~8 copies/µl sample 
input): As1, E1 (NEB) and N2 (DETECTR) targeting 
the Orf1ab, E- and N-gene, respectively (Figure 1C, 
S1B) (Broughton et al., 2020; Rabe & Cepko, 2020; 
Zhang, Ren, et al., 2020). As previously reported 
(Anahtar et al., 2020; Rabe & Cepko, 2020; Zhang, 
Odiwuor, et al., 2020), RT-LAMP reactions with less 
than ~100 target molecules exhibited stochastic on-off 
outcomes. We therefore defined 100 copies per reaction 
as our robust limit of detection. When tested with a 
diluted patient sample, the E1 (NEB) and N2 
(DETECTR) primers performed best with robust 
detection of SARS-CoV-2 up to Cq values of ~33 
(sporadic detection up to Cq 35) (Figure S1B).  
 We next compared our RT-LAMP setup with one-
step RT-qPCR, using RNA isolated from naso-
pharyngeal swabs or gargle lavage from Covid-19 
patients as input (Figure 1D-F). Using E1 or N2 primer 
sets for RT-LAMP, we achieved sensitive and specific 
detection of SARS-CoV-2 in patient samples with RT-
qPCR measured Cq values of up to ~35 (~25 copies per 
reaction), independent of the patient sample type 
(Figure 1E). We obtained 100% positive predictive 
agreement rates between RT-LAMP and RT-qPCR up to 
Cq 33 (~100 copies per reaction) and 100% negative 
predictive agreement rates for qPCR negative samples 
(Figure 1F). E1 and N2 primer sets performed equally 
well, with a robust limit of detection of Cq 33-34 
(Figure 1F). As shown recently (Zhang, Ren, et al., 
2020), different primer sets can be combined in RT-
LAMP reactions in order to reduce the false negative 
rate caused by suboptimal sample quality or by 
mutations in the viral genome coinciding with primer 
binding sites (Artesi et al., 2020). 
 A major bottleneck of certified RT-qPCR-based 
SARS-CoV-2 nucleic acid detection assays is their 
dependence on time-consuming and expensive RNA 
purification from patient samples. Inspired by recent 
findings (Ladha, Joung, Abudayyeh, Gootenberg, & 
Zhang, 2020; Rabe & Cepko, 2020), we assessed 
whether direct sample input/lysis conditions are 
compatible with sensitive RT-LAMP. Besides simple 
heat inactivation, we tested two previously published 
lysis and sample inactivation buffers, namely DNA 
QuickExtract (Lucigen) (Ladha et al., 2020) and the 
‘Cells-to-Ct’ lysis buffer (Joung et al., 2017). To assess 
different lysis conditions, we compared crude lysates 
from serially diluted HEK293 cells to isolated RNA 
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Figure 1: A sensitive, robust RT-LAMP assay compatible with crude patient samples. 
A) Schematic illustrating loop-mediated amplification (LAMP) of SARS-CoV-2 RNA and the regions targeted in this study 
(Orf1ab, E and N genes; depicted above). Each target region is recognized by a defined set of primers (B3, LB, BIP, LF, FIP, 
F3). The RNA template (red) is reverse transcribed and displaced after first-strand synthesis; the outer primer binding sites are 
added in the subsequent amplification step. The resulting dumbbell DNA structure acts as template for further rounds of 
amplification,  ultimately leading to high molecular  weight  amplicons.  B)  Readout of  a  real-time fluorescence RT-LAMP 
reaction using 500 copies of synthetic SARS-CoV-2 (red) or water as non-targeting control (NTC, black) as input. ‘Time to 
threshold’ indicates the time at which the fluorescence value reaches threshold level (equivalent to Cq value in RT-qPCR 
assays), ‘end-point RFU’ indicates the fluorescence value (FAM filter set, absorption/emission at 494 nm/518 nm) after 35 
minutes  reaction  time  (used  throughout  this  study  unless  indicated  otherwise);  RFU:  relative  fluorescence  units.  C) 
Performance of the three top primer sets for RT-LAMP-based SARS-CoV-2 detection. End-point relative fluorescence units 
(RFUs) of RT-LAMP reactions (in duplicates) using the indicated primer sets and serially diluted synthetic SARS-CoV-2 RNA 
standard as input. Water was used as no-target control (NTC). D) Cartoon indicating the workflow for SARS-CoV-2 detection 
by either RT-LAMP or 1-step RT-qPCR from patient samples (nasopharyngeal swab or gargle) with prior RNA isolation. E) 
Comparison of RT-LAMP and RT-qPCR performance. Plotted are RT-LAMP end-point fluorescence values after 35 minutes 
versus the respective RT-qPCR Cq values. RNA was derived from gargle (green) or nasopharyngeal swabs (black); two no-
target controls were included (black cross). Reactions in which no amplification was recorded are labelled as qPCR negative. 
F) Predictive agreement between RT-LAMP and 1-step RT-qPCR assays. Shown are percentages of positive (detected in RT-
LAMP and  RT-qPCR,  black  bars)  and  negative  (not  detected  in  either  RT-LAMP or  RT-qPCR,  purple  bars)  predictive 
agreement for sample groups (defined by RT-qPCR-derived Cq values) between RT-LAMP (using E- and/or N-gene primers) 
and 1-step RT-qPCR. G)  Performance of different crude sample preparation methods in RT-LAMP. Shown are end-point 
relative fluorescence units (RFUs) for RT-LAMP reactions targeting human RNAseP on sample inputs derived from defined 
numbers of HEK293 cells mixed 1:1 with indicated 2x buffers (extracted RNsA served as a positive control). H) Cartoon 
indicating the workflow for RT-LAMP using QuickExtract crude lysate as sample input. I) Comparison of QuickExtract crude 
sample input versus extracted RNA as input using 1-step RT-qPCR. Covid-19 patient nasopharyngeal swabs or gargle samples 
(color coded according to the indicated collection medium) were either processed with the QuickExtract workflow (crude 
sample input) or RNA was extracted using an automated King Fisher RNA bead purification protocol. Reactions in which no 
amplification was recorded are labelled as qPCR negative. J)  Performance of RT-LAMP with QuickExtract treated crude 
Covid-19 patient sample input (same samples as in I). Depicted is the correlation of Cq values from RT-qPCR performed on 
QuickExtract treated samples versus corresponding end-point relative fluorescence units (RFUs) from RT-LAMP reactions.
.CC-BY-NC-ND 4.0 International license(which was not certified by peer review) is the author/funder. It is made available under a
The copyright holder for this preprintthis version posted July 23, 2020. . https://doi.org/10.1101/2020.06.23.166397doi: bioRxiv preprint 
from equivalent numbers of cells as input for RT-LAMP 
reactions targeting the human reference gene RNaseP 
POP7 (Figure 1G). A five-minute incubation of patient 
samples with QuickExtract at 95°C performed equally 
well compared to a standard Trizol RNA extraction step 
(Ladha et al., 2020) (Figure 1G). Follow-up experiments 
substantiated that QuickExtract, in combination with 
heat treatment, preserves RNA integrity even under 
conditions where exogenous RNase A was added 
(Figure S2).  
 To benchmark QuickExtract solution on Covid-19 
patient samples, we performed RT-qPCR on either 
purified patient RNA or crude QuickExtract lysate 
(Figure 1H). Irrespective of the sample type (swab or 
gargle), we observed a strong agreement between the 
corresponding RT-qPCR measurements (Figure 1I). 
Only samples with very low viral titers (high Cq values) 
became undetectable in the QuickExtract samples, 
presumably as ~20-fold less patient material equivalent 
was used compared to reactions using isolated RNA as 
input (Figure 1I). Importantly, RT-LAMP performed 
equally well to extracted RNA when using QuickExtract 
crude sample input across different transport media and 
different sample types (swabs in viral transport medium 
(VTM), swabs in 0.9% NaCl, swabs or gargle in HBSS 
buffer), with a limit of RT-qPCR-measured Cq values of 
33 (~100 copies) and identical predictive performance 
rates (Figure 1J). No false positives were observed, 
demonstrating the high specificity and sensitivity of RT-
LAMP on crude samples lysed and inactivated with 
QuickExtract solution. Heat inactivation with 
QuickExtract, in combination with fluorescent detection 
of the RT-LAMP reaction, is therefore a rapid method to 
detect SARS-CoV-2 in diverse patient samples.   
An efficient cross-contamination prevention system 
 LAMP results in the billion-fold amplification of 
target molecules. This poses a serious yet rarely 
mentioned risk, as only minor work-place or reagent 
contaminations with LAMP reactions will translate into 
large numbers of false positive assays (Kwok & 
Higuchi, 1989). Inspired by previous studies, we tested 
whether RT-LAMP based SARS-CoV-2 detection can be 
combined with a contamination prevention system that 
utilizes dUTP and thermolabile Uracil DNA 
Glycosylase (UDG) (Hsieh, Mage, Csordas, Eisenstein, 
& Tom Soh, 2014; Tang, Chen, & Diao, 2016). In this 
system, dUTP is incorporated into LAMP amplicons 
making them susceptible for Uracil-base cleavage in 
subsequent LAMP reactions containing the UDG 
enzyme (Figure 2A). To mimic carry-over contami-
nations from amplicons of prior LAMP reactions, we 
supplemented pre-RT-LAMP reactions (based on the 
key enzymes RTx and Bst 2.0) with dUTP, followed by 
dilution and addition to reactions in the presence versus 
absence of thermolabile UDG (Figure 2A). 
Thermolabile UDG is active at room temperature yet 
completely inactivated at temperatures above 50°C. In 
the absence of UDG, addition of a one billion-fold 
diluted pre-LAMP product resulted in indistinguishable 
signal in target vs. non-target conditions, illustrating the 
danger of cross-contamination. In contrast, in the 
6
Figure 2: The dUTP/UDG system prevents carry-over cross-contamination in RT-LAMP.
A)  Schematic  depicting  the  principle  of  the  dUTP/UDG  system  in  preventing  carry-over  contamination.  dUTP  is 
incorporated into LAMP amplicons in a primary reaction (pre-RT-LAMP). dUTP containing LAMP products carried over 
into a subsequent reaction (RT-LAMP) are cleaved by UDG prior to LAMP-based amplification, making them unavailable as 
amplification templates. This allows robust discrimination between target and no-target control (left), which is challenged by 
cross-over contamination in the absence of UDG-mediated cleavage (right). B) The dUTP/UDG system minimizes cross-over 
contamination. Shown are performances (time to threshold) of RT-LAMP reactions in the absence (left) or presence (right) of 
thermolabile  UDG when using  synthetic  SARS-CoV-2  (filled  circles)  or  water  (open  circles)  as  input.  Reactions  were 
supplemented  with  the  indicated  dilution  of  a  dUTP-containing  pre-LAMP reaction.  All  reactions  were  performed  in 
duplicates.
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presence of UDG, a 5-minute pre-incubation step at 
room temperature reduced the amplifiable carry-over 
product by more than 1,000-fold, enabling specific 
detection in the presence of considerable cross-over 
contamination product (Figure 2B). We conclude that 
the dUTP/UDG system is compatible with RT-LAMP 
reactions based on Bst 2.0 and RTx and profoundly 
lowers the risk of false positives.  
A robust colorimetric RT-LAMP readout compatible 
with various input samples 
 So far, we used real-time fluorescence (based on an 
intercalating DNA dye) to assess RT-LAMP-based 
target amplification. Given its dependency on 
specialized equipment, this detection method is 
prohibitive for low-resource settings or home-testing. 
Colorimetric detection resulting in a visual color change 
upon target DNA amplification provides an attractive, 
low-cost alternative (Goto, Honda, Ogura, Nomoto, & 
Hanaki, 2009; Tanner, Zhang, & Evans, 2015). Two 
colorimetric concepts are compatible with RT-LAMP: 
First, pH dependent dye indicators such as Phenol Red 
induce a color change from pink to yellow when the pH 
value of the reaction decreases upon DNA amplification 
(Tanner et al., 2015). Due to its pronounced color 
change, this is the most commonly used readout for RT-
LAMP assays. However, the pH-change dependent 
readout requires a weakly buffered reaction solution, 
which poses a great challenge when using crude sample 
inputs with variable pH. A second colorimetric assay 
utilizes metal ion indicators such as hydroxynaphthol 
blue (HNB), which changes color from purple to blue 
upon a drop in free Mg2+ ions, which form a Mg-
pyrophosphate precipitate upon DNA amplification 
(Figure 3A) (Goto et al., 2009).  
 Colorimetric readout, either via Phenol Red or the 
HNB dye, can be performed simultaneously with the 
fluorescent readout in the same RT-LAMP reactions. 
When using synthetic SARS-CoV-2 standard in water as 
input, both colorimetric readouts mirrored the 
fluorescent results (Figure 3B, S3). However, when 
using crude QuickExtract lysate as input, the pH-
dependent readout failed or was inconclusive despite 
successful LAMP-mediated target amplification as 
evidenced by the fluorescent readout (Figure 3C, S3). In 
contrast, the HNB-dependent color change was not 
affected by QuickExtract solution, even when mixed 
with various sample buffers such as VTM, NaCl or 
HBSS (Figure 3C). We suspect that the QuickExtract 
solution is strongly buffered thereby preventing the 
required pH change that is typically generated during 
LAMP.  
 When tested in a clinical setting, RT-LAMP 
coupled to the HNB readout enabled robust detection of 
SARS-CoV-2 in patient samples with RT-qPCR values 
of up to ~34 (corresponding to ~50 copies per reaction 
of reference standard) with no false positives and 100% 
positive predictive agreement up to Cq 33 (~100 copies 
per reaction) (Figure 3D, E, S3A). The detection 
outcome was independent of the sample type, and we 
successful ly used QuickExtract lysate from 
nasopharyngeal swabs, gargle solution or sputum 
samples (Figure 3D, S3B). We conclude that pH-
independent dye formats, such as HNB, are superior in 
colorimetric RT-LAMP detection assays where strongly 
buffered or slightly acidic crude sample preparations are 
used as inputs. 
 To accurately determine the sensitivity threshold of 
HNB RT-LAMP, we generated a systematic dilution 
series of a positive Covid-19 patient sample in 
QuickExtract and used absorbance at 650 nm in a 
microplate reader to unambiguously determine the color 
change (Goto et al., 2009). We tested all dilutions by 
RT-qPCR and HNB RT-LAMP in parallel (Figure 3F, 
G). When considering samples with 650 nm absorbance 
values higher than for any co-measured negative 
control, HNB RT-LAMP allowed specific detection of 
samples up to Cq 34.9 with no false positives (Figure 
3F, G). We conclude that, while read-out by 
fluorescence is the method of choice for high-
throughput settings due to the higher dynamic range, 
direct absorbance measurement of the HNB-induced 
color change offers an attractive, alternative readout for 
large numbers of RT-LAMP reactions performed in 
parallel. 
An RT-LAMP assay with drastically increased 
sensitivity 
 SARS-CoV-2 RT-LAMP assays are roughly ten-
fold less sensitive than conventional RT-qPCR assays. 
When using crude samples as input (i.e. eliminating the 
RNA concentration step by a dedicated extraction), 
sensitivity is further lowered, resulting in a substantial 
false negative rate. To increase the sensitivity of our RT-
LAMP assay, we set out to establish a simple and rapid 
nucleic acid enrichment step. We used carboxylated 
magnetic beads to concentrate RNA from QuickExtract 
lysates on the bead surface in the presence of crowding 
agents and salt (Hawkins, O'Connor-Morin, Roy, & 
Santillan, 1994). We further reasoned that, instead of 
eluting RNA from the beads, adding the RT-LAMP mix 
directly to the dry beads should increase the number of 
viral RNA molecules per reaction by orders of 
magnitude, depending on the sample input volume 
(Figure 4A). We tested this approach, termed bead-
LAMP, by using either bead-enriched or non-enriched 
synthetic SARS-CoV-2 RNA in HeLa cell QuickExtract 
lysate as RT-LAMP input. Indeed, bead-LAMP using 50 
µl QuickExtract lysate as input displayed an at least ten-
fold increase in sensitivity, corresponding to a robust 
limit of detection of ~5 copies per reaction (4/4 
replicates; Cq value of 37-38) (Figure 4B-D). In three 
out of four replicates, bead-LAMP enabled detection of 
as few as 2 copies/µl, and in one replicate even a single 
copy/µl of sample input could be detected (Figure 4B, 
C). Overall, bead-LAMP drastically improved 
performance for samples with low viral titers that were 
non-detectable with regular RT-LAMP (Figure 4B, C, E) 
and reached RT-qPCR-like sensitivity (Figure 4E). The 
fluorescence readout of the bead-LAMP reaction 
exhibited overall lower values yet similar kinetics as 
regular RT-LAMP (Figure S6B), indicating that bead-
LAMP is compatible with real-time kinetic analysis 
alongside colorimetric end-point detection (Figure 4B, 
C). After bead enrichment the recovery rates of 
synthetic SARS-CoV-2 RNA determined by RT-qPCR 
ranged from 68-98%, showing the high efficiency of the 
approach (Figure S4). 
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Figure 3: HNB RT-LAMP enables colorimetric SARS-CoV-2 detection from crude patient samples.
A)  Schematic illustrating the properties of pH-sensitive (Phenol Red, top) and Mg2+ concentration sensitive (hydroxynaphthol 
blue, HNB, bottom) colorimetric readouts for LAMP. Phenol Red interacts with protons (H+) generated during DNA amplification, 
which causes a color change from pink/red to yellow (right: the color range of the Phenol Red-containing colorimetric RT-LAMP 
mastermix (NEB) at relevant pH values). Magnesium pyrophosphate precipitate produced during DNA amplification lowers the 
free Mg2+ concentration, causing a color change of the HNB dye from purple to sky-blue (right: the color range of solutions with 
HNB at relevant Mg2+ concentrations). B) Influence of QuickExtract on HNB RT-LAMP performance. Shown is the colorimetric 
HNB readout  of  RT-LAMP reactions  (after  35  minutes;  in  duplicates)  using  indicated  copy numbers  of  SARS-CoV-2 RNA 
standard in water or QuickExtract and the corresponding co-measured end-point fluorescence values (heatmaps are shown below). 
C) QuickExtract lysis buffer is compatible with HNB colorimetric readout but incompatible with Phenol Red colorimetric readout 
of RT-LAMP reactions. Shown are RT-LAMP reaction outcomes (upper panel: colorimetric readout after 35 minutes, lower panel: 
fluorescent end-point values) when using 500 copies of synthetic SARS-CoV-2 RNA standard in indicated sample media diluted 
1:1 with water or 2x QuickExtract solution as input.  D) HNB RT-LAMP performance on Covid-19 patient samples lysed in 
QuickExtract solution. Shown is the binary colorimetric HNB readout of RT-LAMP reactions (N gene) using indicated patient 
samples (sputum (orange), swab (black), gargle (green)) plotted against the corresponding Cq values from RT-qPCR. E) Predictive 
agreement between HNB RT-LAMP and RT-qPCR assays using patient samples lysed in QuickExtract solution. Samples were 
grouped according to their RT-qPCR Cq values, and the percentage of detected (black) and not detected (purple) samples (based on 
HNB RT-LAMP) of the total number of samples per group was plotted. F) Schematic illustrating the serial dilution grid of a 
Covid-19 positive patient sample (Cq of 28) in QuickExtract. The heatmap (left) indicates Cq values determined by 1-step RT-
qPCR (values above Cq 40 are indicated by black crosses). The grid (right) indicates the binary read-out (black: detected; white: 
not detected) of HNB RT-LAMP as measured by 650 nm absorbance). G) Scatter plot showing HNB RT-LAMP performance 
(measured by 650 nm absorbance) versus qPCR-determined Cq values on the serial dilution grid shown in F, including no-target 
controls  (NTC)  and  a  Covid-19-negative  patient  sample  (qPCR  negative).  Horizontal  dashed  line  indicates  the  maximum 
absorbance obtained for any negative control (y = 0.602).
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 We next tested bead-LAMP on a dilution series of a 
Covid-19 patient sample in QuickExtract (Cq of ~30) 
and observed a similar ten-fold increased sensitivity, 
corresponding to a limit of detection of ~Cq 37 in 
patient samples (Figure S5A). When performing bead-
LAMP on individual Covid-19 patient samples, we 
found a dramatic improvement in the diagnostic 
performance. With the exception of one Covid-19 
positive patient that we were not able to detect via RT-
LAMP for unknown reasons, all qPCR positive samples 
(with Cq values up to ~38) were identified while no 
qPCR negative sample was detected (Figure 4F, G). 
 The boost in sensitivity opened the door for 
establishing a pooled RT-LAMP testing strategy. We 
mixed one crude Covid-19 positive patient gargle 
sample in QuickExtract (Cq ~28) with different volumes 
of a pool of 95 crude SARS-CoV-2 negative gargle 
samples in QuickExtract (Figure 4H, S5B). Each pool 
was tested by standard RT-LAMP and bead-LAMP. 
Without bead enrichment, pools with at least 12.5% (1 
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out of 8) of Covid-19 positive sample were identified. In 
contrast, bead-LAMP enabled detection of all pools 
containing SARS-CoV-2, even the pool containing just 
1% (1 out of 96) of Covid-19 positive sample (Figure 
4I, J, S5C). An independent experiment, in which we 
tested bead-LAMP on a dilution series of a Covid-19 
positive patient of Cq ~30 in QuickExtract HeLa cell 
lysate, led to a similar conclusion: again, the pool 
containing only ~1% of the Covid-19 positive sample 
was detectable only with prior bead enrichment (Figure 
S5D-F). With merely 21 reactions (one entire 96-well 
plate pool, eight column pools, twelve row pools), a 
single positive patient of Cq ~30 can thus be detected 
amongst hundred individuals. We conclude that a cheap, 
fast (~5-10 minutes) and simple pre-enrichment step 
boosts the sensitivity of RT-LAMP ten- to fifty-fold, 
making this approach highly attractive for pooled testing 
strategies. Of note, the bead-based RNA enrichment step 
resulted in RT-LAMP reactions being fully compatible 
with the Phenol Red based colorimetric readout, even 
when QuickExtract lysates were used as input. While 
reactions without bead-enrichment failed to convert to 
yellow, the same input samples showed the 
characteristic color change when pre-purified via the 
bead-enrichment step (Figure S5G).  
A pipette-free RT-LAMP assay for home settings 
 The advancements presented so far provide a 
drastically improved SARS-CoV-2 detection assay 
regarding simplicity, robustness and sensitivity. 
However, our assay still required specialized laboratory 
equipment, such as precision pipettes or temperature-
controlled incubators. We therefore explored approaches 
to adapt the HNB RT-LAMP protocol to home settings. 
In order to make RT-LAMP independent of precision 
pipettes, we adopted a previously reported strategy for 
sample clean-up and transfer using filter paper (Y. Zou 
et al., 2017). Using simple Whatman filter paper 
dipsticks (Figure 5A), we reliably detected SARS-
CoV-2 RNA from Covid-19 patients with medium viral 
titers (Cq ~27) (Figure 5B). In addition, introducing a 
wash step with 130 mM sodium chloride solution 
increased the sensitivity and enabled SARS-CoV-2 
detection in patient samples with Cq values ~32, 
mimicking the sensitivity of standard RT-LAMP assays 
(Figure 5B).  
 Due to their isothermal nature, RT-LAMP reactions 
require stable incubation temperatures of ~62-63°C. 
This can be provided using equipment ranging from 
high-end instruments to the most basal setup where 
boiling and room temperature water are mixed at a 
defined ratio and then kept insulated. We tested a 
commercially available sous-vide heater to create a 
temperature-controlled reaction environment (water 
bath) for home-based testing (Figure 5C). When 
combined with the filter paper-based sample clean-up 
and transfer method, this setup, termed HomeDip-
LAMP, was able to accurately detect, within 35 minutes, 
two out of two viral genes in a Covid-19-positive patient 
gargle sample without false positives among Covid-19 
negative gargle samples (Figure 5D). Detection 
accuracy and reaction speed matched HNB RT-LAMP 
reactions with pipetted sample input and laboratory 
equipment (Figure 5D). Moreover, a simple image 
manipulation (color rotation in RGB space) can convert 
the purple versus sky-blue color difference into more 
easily distinguishable outcomes, especially for an 
untrained user (Figure 5D). Taken together, our findings 
provide a basis for the development of a simple SARS-
CoV-2 detection platform, which can be implemented in 
any low-tech environment. 
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Figure 4: bead-LAMP increases sensitivity of RT-LAMP assays.
A) Schematic illustrating the bead-LAMP workflow in comparison to the regular RT-LAMP workflow. AMPure XP RNA capture 
beads were used at 0.6x of the volume of the sample lysate (0.6x beads). B) Performance of bead-LAMP (+ bead enrichment) vs 
regular RT-LAMP (- bead enrichment) using a synthetic SARS-CoV-2 RNA standard spiked-in at the indicated concentration in 
the original sample into HeLa cell QuickExtract (QE) lysate. 50 µl of crude sample in QE, adjusted to 100 µl final volume with 
1x HBSS was used for bead-enrichment. The image shows HNB end-point colorimetric readout of bead-LAMP and RT-LAMP 
reactions; a magnified view of four wells with beads (top: 5 copies/µl is sky-blue; 2 copies/µl is purple) and without beads 
(bottom: both are purple) is shown on the right. All reactions were performed in technical quadruplicates. C) End-point relative 
fluorescence units (RFUs), with or without prior bead enrichment for reactions shown in B. D) Performance of 1-step RT-qPCR 
using 2 µl of the same crude sample preparations as used in B and C. E) Positive detection rates of 1-step RT-qPCR, RT-LAMP 
and bead-LAMP for reactions shown in B, C and D. F) Performance of bead-LAMP on a Covid-19 positive panel of patient 
samples in QuickExtract. The images depict the HNB colorimetric end-point readout, and the heatmaps underneath show co-
measured end-point relative fluorescence units (RFUs) of RT-LAMP reactions, with or without prior bead enrichment, using eight 
Covid-19-positive and five negative samples as input (P1-P11, Covid-19 patient sample; CS42 and CS46, healthy controls). 100 
µl of crude sample in QE was used for bead-enrichment. Corresponding Cq values were obtained by measuring 2 µl of the same 
QuickExtract (QE) patient samples by 1-step RT-qPCR prior to bead enrichment. G) Bead enrichment increases the sensitivity of 
RT-LAMP. Patient samples from F) were classified as detected or not detected based on the HNB RT-LAMP assay before (left, 
open  circles)  and  after  (right,  filled  circles)  bead  enrichment  and  plotted  against  their  respective  Cq values  obtained  from 
QuickExtract (QE) RT-qPCR (Cq values for qPCR negative samples are labelled as not detected, ND). H) Schematic illustrating 
the pooled testing strategy using bead-LAMP. A single Covid-19 positive patient gargle sample in QuickExtract (Cq ~28; black) 
was mixed with different amounts of 95 pooled SARS-CoV-2 negative samples (all  in QuickExtract;  white) yielding seven 
sample pools with indicated ratios of positive to negative samples. 40 to 100 µl of crude sample in QE was used for bead-
enrichment depending on the pool sizes. For lysate volumes smaller than 100 µl, 1x HBSS was added to obtain a final volume of 
100 µl for bead-LAMP. I) Shown is the performance (measured as time to threshold) of bead-LAMP (filled circles) compared to 
regular RT-LAMP (open circles) on the patient pools defined in H. ND = not detected within 60 minutes of RT-LAMP incubation. 
J) Images showing the endpoint  HNB colorimetric readout (left)  and fluorescent  readout (endpoint  RFU; right)  of  samples 
measured in I) with or without prior bead enrichment.
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A robust RT-LAMP assay using open source enzymes 
for SARS-CoV-2 detection 
 A critical bottleneck in population-scale testing 
efforts using RT-LAMP assays, especially in low-
income countries, is the dependence on an existing and 
robust supply chain for the two enzymes, namely the 
reverse transcriptase (RT) and the Bst DNA Polymerase. 
All our assays so far relied on the patent-protected 
enzymes RTx, a thermostable RT, and Bst 2.0, an 
engineered variant of Bst LF, the Large Fragment of 
DNA polymerase I from Geobacillus stearothermophilis 
used in original LAMP assays (Notomi et al., 2000). 
Given that the sequences of neither enzyme are known, 
we set out to identify open-source enzymes that support 
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Figure 5: HomeDip-LAMP enables SARS-CoV-2 detection in low-resource and home settings.
A) Schematic depicting the HomeDip-LAMP workflow. Samples are mixed 1:1 with QuickExtract lysis buffer and inactivated 
at 95°C for 5 minutes. Cellulose paper dipsticks are loaded by dipping into the crude sample for 30 seconds. After a brief 
washing step (3x dipping into wash buffer), RNA is released into pre-distributed RT-LAMP reaction mixes by 3x dipping. RT-
LAMP reactions  are  performed in  a  water  bath  at  63°C and  read  out  after  35  minutes.  B)  Influence  of  different  wash 
conditions  on  SARS-CoV-2 detection  using  RT-LAMP with  paper  dipstick  sample  transfer.  Heatmap showing end-point 
relative fluorescence units (RFUs) at 30 minutes of RT-LAMP reactions after transferring 2 µl of high titer (++, Cq ~27), 
medium-to-low titer (+, Cq ~32) or negative Covid-19 patient samples in QuickExtract into 8 µl of RT-LAMP reaction mix 
using cellulose paper dipsticks. Dipsticks were washed in between in indicated solutions or transferred without washing. A 
sample series where 2 µl were transferred by pipetting (‘pipette’) is shown alongside (NTC = no target control). C) Image 
showing the water bath setup with a Sous Vide heater (black) for HomeDip-LAMP. Reaction tubes were kept upright and 
submerged using floating plastic pipette tip racks (orange). D) Detection of SARS-CoV-2 using HomeDip-LAMP. Left image 
shows true color readout (HNB dye) of HomeDip-LAMP (left 2 tubes) and pipetted LAMP (right 2 tubes) reactions using a 
Covid-19-positive (+) and -negative (-) patient sample in QuickExtract as input (35 minute end-point; water bath incubation at 
63°C). Amplicons are indicated to the left; the human RNAseP amplicon served as positive control. The image to the right 
shows a color-rotated (180° in RGB space) version of the left images for easier readout.   
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RT-LAMP-based SARS-CoV-2 detection without 
compromising assay performance.  
 We first focused on the Bst DNA Polymerase and 
compared the engineered Bst 2.0 enzyme with the 
wildtype Bst LF counterpart. Bst LF exhibited similar 
overall reaction kinetics and sensitivity compared to Bst 
2.0 (Figure 6A). Although reported to be more salt 
sensitive, Bst LF also allowed robust detection of 
SARS-CoV-2 from crude patient lysate in QuickExtract 
(Figure S6A). An important limitation of Bst LF is its 
incompatibility with the dUTP/UDG system due to its 
apparent inability to efficiently incorporate dUTP 
(Figure S6B). Nevertheless, considering the known 
protein sequence of wildtype Bst LF (GeneBank ID: 
AAB52611.1) and its open-source status, Bst LF is the 
enzyme of choice for settings where engineered Bst 
variants are not available or unaffordable (Bhadra, 
Riedel, Lakhotia, Tran, & Ellington, 2020; Phang, Teo, 
Lo, & Wong, 1995).  
 We next examined the reverse transcription step 
that is required for the robust detection of RNA targets 
in RT-LAMP reactions. Bst polymerases are reported to 
exhibit intrinsic RT activity (Shi, Shen, Niu, & Ma, 
2015). In particular, Bst 3.0 was engineered further from 
Bst 2.0 in order to display elevated intrinsic reverse 
transcriptase (RT) activity and increased amplification 
yield (patent US8993298B1). We thus tested Bst LF, Bst 
2.0 and Bst 3.0 in LAMP reactions lacking the dedicated 
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Figure 6: A sensitive RT-LAMP assay based on open-access enzymes.
A) RT-LAMP performance (measured as ‘time to threshold’) of different Bst DNA polymerase variants in combination with 
NEB’s RTx reverse transcriptase on synthetic SARS-CoV-2 RNA standard. For reactions in which no amplification was 
recorded, ‘time to threshold’ is reported as ‘not detected’ (ND). Reactions were performed in duplicates; water was used as no-
target control (NTC). B) RT-LAMP performance (measured as ‘time to threshold’) of different patent-protected (RTx, 
SuperScript III (SS-III)) and non-patent protected (AMV, HIV-1) reverse transcriptase enzymes in combination with Bst LF 
DNA polymerase on 500 copies/reaction of synthetic SARS-CoV-2 RNA standard. Reactions were performed in technical 
quadruplicates; water was used as no-target control (NTC). For reactions in which no amplification was recorded, ‘time to 
threshold’ is reported as ‘not detected’ (ND). C) RT-LAMP sensitivity performance (measured as ‘time to threshold’) of 
reactions containing NEB RTx or home-made HIV-1 RT, in combination with Bst LF DNA polymerase. Reactions contained 
different amounts of synthetic SARS-CoV-2 RNA standard. Reactions were performed in technical duplicates; water was used 
as no-target control (NTC). For reactions in which no amplification was recorded, ‘time to threshold’ is reported as ‘not 
detected’ (ND). D) Performance of RT-LAMP (measured as ‘time to threshold’) with different enzymatic compositions and 
QuickExtract patient sample as input. A pool of Covid-19 positive patient crude lysates (Pool N1-CDC, Cq 25) and a pool of 
Covid-19 negative crude lysates were tested in technical duplicates. For reactions in which no amplification was recorded, 
‘time to threshold’ is reported as ‘not detected’ (ND). 
.CC-BY-NC-ND 4.0 International license(which was not certified by peer review) is the author/funder. It is made available under a
The copyright holder for this preprintthis version posted July 23, 2020. . https://doi.org/10.1101/2020.06.23.166397doi: bioRxiv preprint 
reverse transcriptase RTx. Bst LF showed no RT activity 
under our assay conditions (Figure S6C), and weak RT 
activity was observed for Bst 2.0 and Bst 3.0 when using 
universal Isothermal Amplification Buffer I (Figure 
S6C). In its optimized, higher-salt buffer (Isothermal 
Amplification Buffer II) Bst 3.0 yielded strong yet non-
specific amplification irrespective of the presence of a 
dedicated RT (Figure 6A, S6C). A CRISPR-Cas12 
collateral cleavage assay (Broughton et al., 2020) on the 
Bst 3.0 LAMP products revealed that Bst 3.0, in the 
absence of a dedicated RT enzyme, led to robust 
amplification of the synthetic standard down to 200 
copies per reaction (Figure S6D-F). However, 
considering the patent-protection and the need for an 
additional detection step for amplicon-specific readout, 
we excluded Bst 3.0 as a possible entry point into an 
open-source RT-LAMP reaction. Instead, we concluded 
that a dedicated RT enzyme is required for efficient and 
specific target amplification.  
 To identify a thermostable, open-source RT that is 
active under the reaction conditions of LAMP, we first 
compared several RTs with the engineered RTx enzyme 
using synthetic SARS-CoV-2 RNA as template. We 
limited our test to RTs known to be active at elevated 
temperatures, namely AMV, Superscript III (SS-III) and 
a wildtype version of HIV-1 RT (Martín-Alonso, Frutos-
Beltrán, & Menéndez-Arias, 2020). We found that 
wildtype HIV-1 RT worked equally well in terms of 
efficiency, speed and sensitivity as commercial RTx 
(Figure 6B, C), while AMV and SuperScript-III showed 
only limited RT activity (Figure 6B, S7A). Moreover, 
wildtype HIV-1 RT in combination with Bst LF was 
fully compatible with SARS-CoV-2 detection in crude 
patient samples (Figure 6D). As such, RT-LAMP with 
HIV-1 RT and Bst LF was able to detect SARS-CoV-2 
RNA in a pool of Covid-19 positive patients but not in a 
pool of Covid-19 negative lysates (Figure 6D, S7B). 
Reaction speed in crude patient lysates was slightly 
reduced compared to the gold-standard RT-LAMP 
reaction using RTx and Bst 2.0, yet initiated still within 
20 minutes (Figure 6D, S7B). We conclude that the 
combination of wildtype HIV-1 RT and Bst LF are fully 
able to perform RT-LAMP under our optimized reaction 
conditions with crude patient samples as input. These 
findings open the door for any laboratory to establish 
their own, home-made RT-LAMP reaction mix to enable 
SARS-CoV-2 and other pathogen testing.  
Discussion 
 RT-LAMP is an inexpensive and specific nucleic 
acid detection assay that provides test results in about 
thirty minutes. Its independence from specialized 
laboratory equipment and its compatibility with crude 
patient samples as well as colorimetric visual readout 
make it highly attractive for settings with limited 
resources or for population-scale testing. In this study, 
we systematically optimized every step of the RT-
LAMP assay for crude sample input to make it more 
sensitive, more robust and simpler. Our improved assay 
holds the promise to contribute towards effective 
containment of the current SARS-CoV-2 pandemic. 
 Certified SARS-CoV-2 diagnostic workflows 
include an expensive and lengthy RNA isolation step. 
To circumvent this problem, several crude sample 
inactivation protocols have been developed that are 
compatible with direct downstream reverse transcription 
and amplification steps (Ladha et al., 2020; Myhrvold et 
al., 2018; Rabe & Cepko, 2020). While these 
advancements have simplified SARS-CoV-2 detection 
considerably, the required buffered solutions or reducing 
agents present a challenge for the commonly used pH 
indicator-based colorimetric LAMP readout. For 
example, strongly buffered lysis solutions such as 
QuickExtract are not compatible with Phenol Red dye 
detection, resulting in substantial false negative rates. 
Similarly, false positives have been reported for patient 
sample types with acidic pH such as saliva (Lalli et al., 
2020). We employed the known metal indicator 
hydroxynaphthol blue (HNB) as a robust alternative for 
colorimetric detection of SARS-CoV-2 with no false 
positives and detection rates identical to highly sensitive 
fluorescent LAMP assays for any tested sample buffer 
(Figure 3, S3). HNB RT-LAMP, particularly when 
employed in combination with the dUTP/UDG cross-
contamination prevention system (Figure 2), is therefore 
a highly robust and stream-lined assay suited for SARS-
CoV-2 testing in home settings. 
 A major drawback of using patient samples directly 
for nucleic acid detection is the resulting drop in 
sensitivity. While an upstream RNA isolation step 
allows the concentration of viral template molecules, 
this is not the case for crude extraction methods. With a 
robust limit of detection of ~50-100 copies per reaction, 
RT-LAMP with crude patient sample input can only 
detect medium to high viral titers. Our development of 
bead-LAMP, a simple RNA enrichment protocol with 
magnetic beads, sets the stage for highly sensitive 
SARS-CoV-2 detection in samples from individual 
patients or patient pools (Figure 4). While similar to a 
recently reported protocol based on silica particles 
(Rabe & Cepko, 2020), our approach requires only a 
magnet and adds just 5-10 minutes to the standard 
protocol. Bead-LAMP does not require centrifugation 
and can be performed manually with a simple magnet, 
an automated magnetic particle processor like the 
KingFisher or on fully automated liquid handling 
platforms. It is especially suited for mass-scale pathogen 
surveillance via sample pooling strategies. Combined 
with the HNB colorimetric read-out, bead-LAMP allows 
for screening hundreds of individuals in pooled 
reactions in simple PCR strips. Bead-LAMP is also an 
attractive alternative to ultra-sensitive RT-qPCR when 
used on single patient samples (Figure 4F, G).  
 To illustrate the practical implications of assay 
sensitivity, we used our RT-qPCR data from 
nasopharyngeal swabs to calculate viral copies per 
entire clinical sample as done in (Wölfel et al., 2020). 
Figure S8A shows that the viral titer per sample ranges 
from ~650 to 2x108 viral RNA copies. Grouping patient 
samples according to their ability to infect cells in 
culture (>106 viral copies per swab) (Wölfel et al., 2020) 
further allows to separate them roughly into infectious 
and non-infectious groups. RT-qPCR coupled to RNA 
isolation is able to detect this enormous range of viral 
titers (down to 5 copies per reaction) (Corman et al., 
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2020). Without distinguishing between infectious or 
non-infectious individuals, RT-LAMP on purified RNA 
(limit of detection: 100 copies per RT-LAMP reaction) 
would detect ~ 80% of all infected individuals (Figure 
S8B). RT-LAMP on QuickExtract lysate directly 
prepared from crude sample lowers the number of 
detectable individuals to 64% or 50% when swab 
volumes of 0.5 ml or 3 ml are used, respectively. In 
contrast, the theoretical detection rate of bead-LAMP is 
~92% relative to RT-qPCR on extracted RNA, when 
considering 100% RNA recovery on beads, and up to 
86% when taking the average 77% recovery measured 
with our protocol (Figure S4) into account. Of note, 
bead-LAMP is more sensitive than RT-qPCR performed 
on crude QuickExtract lysate, which detects ~80% of 
infected individuals in our experiments. It is important 
to note that infectious patients are identified at 100% 
detection rate in all RT-LAMP detection formats, 
highlighting the relevance of RT-LAMP for population 
screening. Taken together, in combination with 
minimizing sample volumes of nasopharyngeal swabs, 
bead-LAMP, without a dedicated RNA purification step, 
reaches the sensitivity that is currently defined by gold-
standard certified RT-qPCR assays. At the same time, 
bead-LAMP outperforms RT-qPCR in terms of speed, 
cost (~1.5 USD for commercial QuickExtract & RT-
LAMP reagents plus 0.1 – 0.25 USD for commercial 
magnetic beads per reaction), and low equipment needs.  
 While bead-LAMP enables pooled testing, reliable 
and sensitive home-tests provide important alternative 
strategies in combating the Covid-19 pandemic (Taipale, 
Romer, & Linnarsson, 2020). Towards this end, we 
present a simple strategy for sample RNA binding and 
transfer using cellulose paper strips. With HomeDip-
LAMP, SARS-CoV-2 detection can be performed in 
home settings without the use of pipettes (Figure 5). 
Only sample inactivation buffer, paper-strips, wash and 
reaction solution together with a stable heat-source such 
as a water bath are required. We envision that a 
combination of bead-LAMP with HomeDip-LAMP 
could be adapted for sensitive home testing. In such a 
combined approach, beads could be added to the 
inactivated sample, followed by binding to a magnetic 
rod and dipping as described for cellulose paper strips.  
 Establishing RT-LAMP based SARS-CoV-2 testing 
in developing countries is severely hampered by 
unreliable or non-existing supply chains. The gold-
standard RT-LAMP enzymes Bst 2.0 and RTx are 
engineered and proprietary enzymes, making their on-
site production impossible. In our tests, the wildtype Bst 
LF enzyme performed equally well to Bst 2.0, with the 
exception of dUTP incorporation. One of our most 
significant findings was the identification of a wildtype 
HIV-1 RT enzyme as an eye-level alternative to the RTx 
enzyme. Bst LF and HIV-1 RT can be recombinantly 
produced at high yields using simple molecular biology 
equipment (Boretto et al., 2001; Matamoros et al., 
2005). The implications of our identification of open-
access enzymes that support rapid and sensitive RT-
LAMP are profound: in principle, any molecular 
biology lab in the world will be able to generate a robust 
and sensitive in-house RT-LAMP reaction mix.  
 In summary, our improvements over existing RT-
LAMP workflows enable the robust, in-expensive and 
ultra-sensitive detection of SARS-CoV-2. Our findings 
provide the basis for future clinical performance studies 
with the ultimate goal to make ‘testing for everyone’ a 
reality. Combating the Covid-19 pandemic will require 
access to diagnostic tests in all countries ("The 
COVID-19 testing debacle," 2020). Our establishment 
of an RT-LAMP assay using only open-access enzymes 
is a major step forward to meet precisely this need. 
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Materials and Methods 
Clinical sample collection
Nasopharyngeal swabs were collected in 1.5-3 ml VTM, 
0.9% NaCl solution or 1x HBSS (Gibco: 140 mM NaCl, 
5 mM KCl, 1 mM CaCl2, 0.4 mM MgSO4-7H2O, 0.5 
mM MgCl2-6H2O, 0.3 mM Na2HPO4-2H2O, 0.4 mM 
KH2PO4,  6  mM D-Glucose,  4  mM NaHCO3).  Gargle 
samples were collected from swab-matched patients by 
letting individuals gargle for 1 minute  with 10 ml of 
HBSS or 0.9% Saline solution.  Sputum samples were 
prepared  by  mixing  sputum  material  1:1  with  2x 
Sputolysin  solution  (6.5  mM  DTT  in  HBSS)  and 
incubation  at  room  temperature  for  15  minutes. 
Informed consent was obtained from all patients.
RNA extraction from patient material
Total RNA was isolated from 100 µl of nasopharyngeal 
swabs  or  cell-enriched gargling solution using a  lysis 
step  based  on  guanidine  thiocyanate  (adapted  from 
Boom et al. 1990) and 20 µl of carboxylated magnetic 
beads (GE Healthcare,  CAT:65152105050450) applied 
in 400 µl of Ethanol on the magnetic particle processor 
KingFisher  (Thermo).  After  a  5-minute  incubation  at 
room temperature, DNA was digested with DNaseI for 
15 mins at  37°C, followed by a series of wash steps. 
RNA was eluted from the beads in 50 µl RNase free 
H2O for 5 minutes at 60°C. 
Crude sample inactivation using QuickExtract DNA 
solution
50  µl  of  nasopharyngeal  swabs,  gargle  solution  or 
sputum sample were mixed 1:1 with 2x QuickExtract 
DNA extraction solution (Lucigen) and heat inactivated 
for 5 minutes at 95°C. Samples were then stored on ice 
until further use or frozen at -80°C.
RT-qPCR
For detecting the viral N-gene via RT-qPCR, 1-step RT-
qPCR was performed using the SuperScript III Platinum 
One-Step  qRT-PCR  Kit  (Thermofisher)  or  Luna 
Universal One-Step RT-qPCR Kit (NEB) and 1.5 µl of 
reference primer/probe sets CDC-N1 (IDT 10006713) or 
CDC-N2 (IDT 10006713) per 20 µl reaction. Reactions 
were run at 55°C for 15 minutes, 95°C for 2 minutes, 
followed by 45 cycles of 95°C for 10 seconds and 55°C 
for 45 seconds in a BioRad CFX qPCR cycler. Each RT-
qPCR reaction contained either 5 µl (N-gene, extracted 
RNA) or 2 µl (N-gene, QuickExtract lysate) of sample 
input per 20 µl reaction.
Fluorescent RT-LAMP
Fluorescent RT-LAMP reactions were set up using the 
NEB Warmstart  RT-LAMP kit  or  individual  enzymes. 
For  reactions  using the  RT-LAMP kit,  Warmstart  RT-
LAMP master mix (1x final, 2x stock) was mixed with 
primer solution (1x final, 10x stock) containing all six 
LAMP primers (B3, F3, LB, LB, FIP, BIP), LAMP dye 
(1x  final,  50x  stock)  or  Syto9  (1  µM  final,  50  µM 
stock),  sample  and  nuclease-free  water.  Primers  were 
used at final concentrations of 0.2 µM for F3/B3, 0.4 
µM for LB/LF (except for N2 DETECTR, LB/LF 0.8 
µM) and  1.6  µM FIP and  BIP.  Typical  final  reaction 
volumes were 10 µl or 20 µl containing 2 µl of sample. 
For LAMP reactions using individual polymerases, RT-
LAMP reactions were set up using NEB 1x Isothermal 
Amplification Buffer (Bst LF, Bst 2.0, Bst 3.0) or NEB 
1x Isothermal Amplification Buffer II (Bst 3.0), 6 mM 
MgSO4  (8  mM  final;  2  mM  MgSO4  are  present  in 
Isothermal  Buffer  I),  0.3  U/µl  NEB  Warmstart  RTx, 
0.32 U/µl NEB Bst DNA polymerase (LF, 2.0 or 3.0), 
1.4 mM of each dNTP (Larova, 25 mM of each dNTP 
stock  solution),  1x  fluorescent  dye  or  1  µM  Syto9, 
sample and nuclease-free water.
For LAMP reactions testing individual RT-enzymes, RT-
LAMP reactions were set up using NEB 1x Isothermal 
Amplification Buffer (Bst LF, Bst 2.0, Bst 3.0) or NEB 
1x Isothermal Amplification Buffer II (Bst 3.0), 6 mM 
MgSO4  (8  mM  final;  2  mM  MgSO4  are  present  in 
Isothermal Buffer I), 1.4 mM of each dNTP (Larova, 25 
mM of each dNTP stock solution),  0.32 U/µl NEB Bst 
DNA polymerase (LF, 2.0 or 3.0), 0.3 U/µl, Warmstart 
RTx  (NEB),  0.2  U/µl  AMV  RT  (NEB),  4  U/µl 
SuperScript  III  (Thermofisher),  50 nM of  home-made 
HIV-1 RT (BH10) diluted in 1x dilution buffer (TrisHCl 
pH  7.5,  50  mM  NaCl,  0.5  mM  TCEP)  and  1x 
fluorescent dye or 1 µM Syto9, sample and nuclease-
free water. 
Reactions were run at 63°C (62°C for N2 DETECTR 
and primer comparison) for 30-60 minutes in a BioRad 
CFX Connect qPCR cycler with SYBR readings every 
minute. 
Direct sample lysis buffer test
HEK293 cells were trypsinized and counted to make the 
appropriate  dilutions  in  HBSS.  The  dilutions  were 
mixed 1:1 with respective lysis buffers and treated as 
follows:  Cells  for  no  extraction  were  incubated  for  5 
min  at  room temperature.  QuickExtract  samples  were 
incubated at 95˚C for 5 min. Cells lysed in the home-
made  buffer  (19.2  mM  Tris–HCl  (pH  7.8),  1  mM 
MgCl2,  0.88  mM  CaCl2,  20  μM  DTT,  2%  (wt/vol) 
Triton  X-100)  were  incubated  for  5  min  at  room 
temperature before incubation at  95˚C for  5 min.  For 
extracted RNA, RNA was purified from 1e5 HEK293 
cells using standard Trizol RNA extraction and diluted 
to cell/reaction equivalents.
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dUTP/UDG contamination prevention system
Reactions  were  set  up  to  contain  NEB 1x Isothermal 
Amplification  Buffer,  1.4  mM  of  each  dATP,  dCTP, 
dGTP,  0.7  mM dUTP,  0.7  mM dTTP,  6  mM MgSO4 
(100  mM  stock,  NEB),  0.32  U/µl  NEB  Bst  2.0 
polymerase,  0.3  U/µl  NEB  Warmstart  RTx  Reverse 
Transcriptase,  0.2  U/µl  NEB  Antarctic  thermolabile 
UDG, sample and nuclease-free water. Reactions were 
set up on ice and incubated at room temperature for 5 
minutes  before  being transferred to  63°C to  start  RT-
LAMP reactions  under  standard  conditions  described 
above.  For  demonstrating  carry-over  contamination, 
reactions  either  contained  UDG  (+UDG)  or  water  (-
UDG) and different amounts of pre-amplified RT-LAMP 
product (pre-RT-LAMP). Pre-RT-LAMP reactions were 
performed with dUTP, E-gene primer and 500 copies of 
Twist synthetic RNA standard for 60 minutes at 63°C. 
Serial  dilutions were made by mixing 1 µl  of  dUTP-
containing  pre-RT-LAMP  product  with  999  µl  of 
nuclease-free water  to  get  1e3-,  1e6-,  1e9-  and 1e12-
fold dilutions of pre-RT-LAMP, followed by addition of 
2 µl diluted pre-RT-LAMP product to dUTP/UDG RT-
LAMP reactions.
Colorimetric LAMP
For  HNB  colorimetric  RT-LAMP detection,  reactions 
were  set  up  as  in  fluorescent  RT-LAMP  with  the 
addition of 120 µM HNB dye solution (20 mM stock in 
nuclease-free water). Phenol Red colorimetric reactions 
were performed using the NEB WarmStart colorimetric 
LAMP  2x  master  mix  and  the  same  final  primer 
concentrations  as  in  fluorescent  RT-LAMP reactions. 
HNB  and  Phenol  colorimetric  reactions  further 
contained  1x  fluorescent  LAMP dye  (50x  stock  from 
LAMP  kit)  or  1  µM  Syto9  dye  (50  µM  Stock)  to 
measure fluorescence in parallel.
Bead-LAMP
For  bead  enrichment,  variable  volumes  of  sample  in 
QuickExtract (40 µl up to 100 µl) were adjusted to a 
final volume of 100 µl with HBSS, mixed with 0.6x of 
beads (1:5 dilution of Agencourt RNAClean XP in 2.5 
M  NaCl,  10  mM  Tris-HCl  pH  8.0,  20%  (w/v)  PEG 
8000, 0.05% Tween 20, 5 mM NaN3) and incubated for 
5  minutes  at  room temperature.  Beads  were  captured 
with a magnet for 5 minutes and then washed twice with 
85% ethanol for 30 seconds. The beads were air dried 
for  5  minutes  and  then  eluted  directly  in  20  µl 
colorimetric  HNB LAMP reaction  mix  containing  1x 
NEB WarmStart LAMP kit, 1x Fluorescent LAMP dye, 
120  µM  HNB  dye  solution  and  1x  primer  mix.  No 
additional volume for dry beads was factored into the 
RT-LAMP  reaction  mix  such  that  reactions  were 
completed  with  nuclease  free  water  to  have  final 
reaction volumes of 20 µl.
As sample input for pooled bead-LAMP (Figure 4H-J, 
S5B-D), sample pools were prepared by mixing 10 µl of 
a  Covid-19  positive  patient  gargle  sample  in 
QuickExtract  with  different  amounts  of  a  Covid-19 
negative gargle sample pool (n=95) in QuickExtract (10 
µl per sample). For pool volumes <100 µl, the volume 
was filled up to 100 µl with HBSS:QuickExtract (1:1); 
for pool volumes >100 µl,  an aliquot of 100 µl were 
taken  out  after  pooling  for  subsequent  RT-LAMP or 
bead-LAMP.  40  µl  (matching  the  smallest  pooled 
sample  volume)  of  a  Covid-19  positive  or  negative 
patient  gargle  sample  were  used  as  positive  (qPCR 
positive) or negative (qPCR negative) controls, and also 
filled up to 100 µl with HBSS:QuickExtract (1:1) before 
LAMP.
As  sample  input  for  the  proof-of-concept  experiment 
shown  in  Figure  S5D-F,  sample  pools  containing 
different  numbers  of  Covid-19  positive  patient  gargle 
sample  in  QuickExtract  were  mixed  with  HeLa  cell 
lysate  in  QuickExtract.  The  HeLa  cell  lysate  was 
prepared by adding 500 µl of HBSS and 500 µl of 2x 
QuickExtract solution to a HeLa cell pellet containing 
one million cells, followed by cell lysis for 5 minutes at 
95°C. The stock lysate of 1000 cells/µl was then diluted 
in 1x heat inactivated QuickExtract buffer (diluted to 1x 
in HBSS) to a final concentration of 20 cells/µl.  This 
concentration was chosen as QuickExtract lysate from 
gargle or swabs roughly yields 200 pg/µl of RNA or 20 
cells/µl.  This  Covid-19  negative  QuickExtract  lysate 
was  used  to  spike-in  various  amounts  of  Covid-19 
positive patient QuickExtract lysate. 
Bead-LAMP using Phenol Red as colorimetric read-out 
(Figure  S5G)  was  performed  with  WarmStart 
colorimetric LAMP 2x master mix (NEB) instead of the 
HNB containing RT-LAMP mix. 
Assessment of bead enrichment
For  evaluation  of  the  recovery  rate  after  bead 
enrichment different dilutions of Twist synthetic SARS-
CoV-2 RNA standard were made in HeLa cell lysate. 40 
µl of sample was adjusted to 100 µl with QuickExtract 
diluted 1:1 with HBSS. Bead enrichment was performed 
as described for bead-LAMP. Nucleic acids were eluted 
with 20 µl nuclease-free water for 5 minutes at 63˚C. 
SARS-CoV-2 RNA concentrations were determined in 
the  input  (before  enrichment)  and  eluate  (after  bead 
enrichment) by RT-qPCR.
HomeDip-LAMP
Reactions for HomeDip-LAMP were set up as for HNB 
colorimetric  LAMP,  with  final  reaction  volumes 
(excluding  sample  volume)  being  25  µl.  Filter  paper 
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dipsticks (dimensions:  2x10 mm) were cut  from filter 
paper  (Fisher  Scientific,  cat.  number  09-790-14D). 
Using forceps, dipsticks were dipped into 2 µl of patient 
sample for 30 seconds, allowing the liquid to be drawn 
entirely  onto  the  paper.  The  paper  strips  were  then 
washed by rapidly submerging (‘dipping’)  three times 
into  wash  solution,  typically  130  mM  NaCl.  Sample 
strips were then dipped three times into the PCR tubes 
containing  25  µl  of  pre-distributed  HNB  RT-LAMP 
reaction mixes. The RT-LAMP reaction was performed 
for  35 minutes  in  a  water  bath that  was temperature-
controlled by a sous-vide heater (Allpax) set to 63°C. 
PCR  tubes  were  kept  upright  and  submerged  during 
incubation by floating pipette tip racks.
Preparation of crRNAs for Cas12 detection
LbaCas12a  guide  RNAs  were  ordered  as  reverse 
complementary Ultramers from IDT. A T7-3G minimal 
promoter  sequence  was  added  for  T7  in  vitro 
transcription. 1 µM Ultramer was annealed with 1 µM 
T7-3G oligonucleotide in 1x Taq Buffer (NEB) in a final 
volume of 10 µl by heating the reaction up to 95°C for 5 
minutes, followed by slowly cooling down to 4°C with a 
0.8°C/seconds ramp rate. One microliter of 1:10-diluted 
annealing reaction was used for T7 in vitro transcription 
using the Invitrogen MEGAScript T7 Transcription kit 
following  the  manufacturer  instruction.  RNA  was 
transcribed  for  16  hours  at  37°C  and  purified  using 
AmpureXP RNA beads following instructions described 
in (Kellner,  Koob, Gootenberg, Abudayyeh, & Zhang, 
2019).
Cas12-detection of RT-LAMP product
RT-LAMP was  set-up  as  described  above  and  run  at 
62°C  for  60  minutes.  Meanwhile,  50  nM  purified 
crRNA  was  mixed  with  62.5  nM  EnGen  LbCas12 
(NEB) in 1x NEB Buffer 2.1 and a final volume of 20 
µl.  The  RNP  complex  was  then  incubated  for  30 
minutes in a heat-block and kept on ice until use. For 
detection, 2 µl of the RT-LAMP product and 125 nM 
ssDNA  sensor  (Invitrogen,  DNaseAlert  HEX 
fluorophor)  were  added  to  20  µl  of  the  Cas12-RNP 
complex  on  ice.  Reporter  cleavage  was  monitored  in 
real-time  using  a  BioRad  QFX  qPCR  cycler  with 
measurements taken every 5 minutes for a total of 60 
minutes.
Expression and purification of HIV-1 RT
Recombinant  heterodimeric  HIV-1  RT  (strain  BH10, 
GenBank accession number AH002345) was expressed 
and  purified  using  a  modified  version  of  plasmid 
p66RTB, as previously described (Boretto et al., 2001; 
Matamoros  et  al.,  2005).  HIV-1  RT  p66  subunits 
carrying  a  His6  tag  at  their  C-terminus  were  co-
expressed  with  the  HIV-1  protease  using  the 
Escherichia coli XL1 Blue strain. The resulting p66/p51 
heterodimers  were  purified  to  homogeneity  by  ionic 
exchange  on  cellulose  phosphate  P11  (Whatman), 
followed  by  affinity  chromatography  on  Ni2+–
nitriloacetic–agarose  (ProBond™  resin,  Invitrogen). 
HIV-1 RT-containing fractions were pooled and dialyzed 
against 50 mM Tris-HCl pH 7.0 buffer, containing 25 
mM NaCl, 1 mM EDTA, 10% (w/v) glycerol, and 1 mM 
DTT.  After  dialysis,  enzymes  were  concentrated  by 
centrifugation  in  Centriprep®  30K  and  Amicon® 
Ultra-4 Ultracel®-10K devices (Merck Millipore Ltd). 
Purity  of  enzymes  was  assessed  by  SDS–
polyacrylamide  gel  electrophoresis.  RT concentrations 
were determined spectrophotometrically by assuming a 
molar extinction coefficient of 2.6×105 M−1 cm−1 at 280 
nm. RT active-site titration was carried out as previously 
described  (Kati,  Johnson,  Jerva,  &  Anderson,  1992; 
Menéndez-Arias, 1998). 
Assessment of SARS-CoV-2 detection rates (related 
to Discussion)
Measured  RT-qPCR  Cq  values  from  clinical  samples 
presented  in  Figure  1E  and  1I  were  transformed  to 
copies per reaction using Cq 30 = 1000 copies/reaction 
(determined  in  Figure  S4B)  as  reference.  For 
calculations, entire swab volumes were set to 3 ml, from 
which 100 µl were used for RNA extractions (eluted in 
50  µl;  5  µl  of  RNA per  RT-qPCR)  and  bead-LAMP. 
QuickExtract lysates were prepared with 2x buffer, and 
2 µl were used for RT-qPCR or RT-LAMP. Copies per 
reaction were then transformed to equivalent copies per 
original  sample  volume used  for  reactions  (20  µl  for 
extracted RNA, 1 µl of QuickExtract crude lysate), and 
projected to 3 ml total swab volumes. Detection rates 
were  calculated  by  dividing  the  number  of  detected 
samples  for  each  procedure  by  the  total  number  of 
detected individuals measured by RT-qPCR on extracted 
RNA (most sensitive method). A robust detection limit 
of 100 copies/reaction was used for RT-LAMP, and 5 
copies/reaction  for  RT-qPCR.  Depending  on  the 
respective  purification  strategy,  up  to  100x  fold 
enrichment can be achieved (bead-LAMP) from 100 µl 
original sample.
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Primer sequences for RT-LAMP 
name sequence reference 
DETECTR N-gene F3 AACACAAGCTTTCGGCAG (Broughton et al., 2020) 
DETECTR N-gene B3 GAAATTTGGATCTTTGTCATCC  
DETECTR N-gene FIP TGCGGCCAATGTTTGTAATCAGCCAAGGAAATTTTGGGGAC  
DETECTR N-gene BIP CGCATTGGCATGGAAGTCACTTTGATGGCACCTGTGTAG  
DETECTR N-gene LF TTCCTTGTCTGATTAGTTC  
DETECTR N-gene LB ACCTTCGGGAACGTGGTT  
   
NEB E1-F3 TGAGTACGAACTTATGTACTCAT (Zhang, Ren, et al., 2020) 
NEB E1-B3 TTCAGATTTTTAACACGAGAGT  
NEB E1-FIP ACCACGAAAGCAAGAAAAAGAAGTTCGTTTCGGAAGAGACAG  
NEB E1-BIP TTGCTAGTTACACTAGCCATCCTTAGGTTTTACAAGACTCACGT  
NEB E1-LB GCGCTTCGATTGTGTGCGT  
NEB E1-LF CGCTATTAACTATTAACG  
   
As1_F3 CGGTGGACAAATTGTCAC (Rabe & Cepko, 2020) 
As1_B3 CTTCTCTGGATTTAACACACTT  
As1_LF TTACAAGCTTAAAGAATGTCTGAACACT  














   
NEB N-gene-A-F3 TGGCTACTACCGAAGAGCT 
(Zhang, Odiwuor, et al., 
2020) 
NEB N-gene-A-B3 TGCAGCATTGTTAGCAGGAT  
NEB N-gene-A-FIP TCTGGCCCAGTTCCTAGGTAGTCCAGACGAATTCGTGGTGG  
NEB N-gene-A-BIP AGACGGCATCATATGGGTTGCACGGGTGCCAATGTGATCT  
NEB N-gene-A-LF GGACTGAGATCTTTCATTTTACCGT  
NEB N-gene-A-LB ACTGAGGGAGCCTTGAATACA  
   
NEB N2-F3 ACCAGGAACTAATCAGACAAG (Zhang, Ren, et al., 2020) 
NEB N2-B3 GACTTGATCTTTGAAATTTGGATCT  
NEB N2-FIP TTCCGAAGAACGCTGAAGCGGAACTGATTACAAACATTGGCC  
NEB N2-BIP CGCATTGGCATGGAAGTCACAATTTGATGGCACCTGTGTA  
NEB N2-LF GGGGGCAAATTGTGCAATTTG  
NEB N2-LB CTTCGGGAACGTGGTTGACC  
   
DETECTR RNaseP POP7 F3 TTGATGAGCTGGAGCCA (Broughton et al., 2020) 
DETECTR RNaseP POP7 B3 CACCCTCAATGCAGAGTC  
DETECTR RNaseP POP7 FIP GTGTGACCCTGAAGACTCGGTTTTAGCCACTGACTCGGATC  
DETECTR RNaseP POP7 BIP CCTCCGTGATATGGCTCTTCGTTTTTTTCTTACATGGCTCTGGTC  
DETECTR RNaseP POP7 LF ATGTGGATGGCTGAGTTGTT  
DETECTR RNaseP POP7 LB CATGCTGAGTACTGGACCTC  
   
ACTB-F3 AGTACCCCATCGAGCACG (Zhang, Ren, et al., 2020) 
ACTB-B3 AGCCTGGATAGCAACGTACA  
ACTB-FIP GAGCCACACGCAGCTCATTGTATCACCAACTGGGACGACA  
ACTB-BIP CTGAACCCCAAGGCCAACCGGCTGGGGTGTTGAAGGTC  
ACTB-LoopF TGTGGTGCCAGATTTTCTCCA  
ACTB-LoopB CGAGAAGATGACCCAGATCATGT  
 
RT-qPCR primers and probes 
name sequence reference 
CDC-N1-F GACCCCAAAATCAGCGAAAT CDC  
CDC-N1-R TCTGGTTACTGCCAGTTGAATCTG CDC  
CDC-N1-P FAM-ACCCCGCATTACGTTTGGTGGACC-BHQ1 CDC  
CDC-N2-F TTACAAACATTGGCCGCA AA CDC  
CDC-N2-R GCGCGACATTCCGAAGAA CDC  
CDC-N2-P FAM-ACAATTTGCCCCCAGCGCTTCAG-BHQ1 CDC  
 
Oligos for crRNAs for LbaCas12a  
name sequence reference 




(Broughton et al., 2020) 
T7-3G IVT primer  GAAATTAATACGACTCACTATAGGG (Kellner et al., 2019) 
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Figure S1: Primer performance for the detection of SARS-CoV-2 by RT-LAMP. 
A) Amplification curves (real-time fluorescent measurements; in duplicates) from RT-LAMP reactions shown in 
Figure 1C. Curves using synthetic SARS-CoV-2 RNA standard dilutions as input are in color (color-code 
indicates different primer sets; yellow: As1 Orf1ab; red: E-gene E1 NEB; blue: N-gene N2 DETECTR). Curves 
using non-targeting controls (NTC) as input are shown in black. B) Heatmap showing end-point relative 
fluorescence values (after 35 minutes) of RT-LAMP reactions (in duplicates; respective primers indicated to the 
left) using Covid-19 patient samples with indicated Cq values (determined via RT-qPCR and the N1-CDC 
amplicon) as input. Reactions with primers targeting the human ACTB gene served as sample quality control. All 
reactions were performed in duplicates. 
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Figure S2: QuickExtract buffer combined with heat inhibits RNase activity. 
Shown are relative fluorescence values over time (upper graph) and end-point fluorescence values (lower 
graph) of RNaseAlert reactions in HBSS buffer or 1x QuickExtract, in the presence or absence of RNase A 
and with or without incubation at 95°C. All reactions were performed in duplicates. 
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Figure S3: HNB RT-LAMP shows robust performance on QuickExtract-treated patient sample material. 
A) Comparison between Phenol Red and HNB colorimetric readout of RT-LAMP reactions (in duplicates) on serially 
diluted synthetic SARS-CoV-2 RNA in water (left) or 1x QuickExtract (right). End-point fluorescence values measured 
in parallel are shown in heatmaps below. While fluorescent detection indicates successful LAMP in both sample 
matrices, Phenol Red but not HNB colorimetric readout is inconclusive in QuickExtract buffer (right panel, top rows). 
B) HNB RT-LAMP performance across a wide range of Covid-19 patients and sample types. Images showing the HNB 
end-point outcome of RT-LAMP reactions on multiple Covid-19 patient samples (gargle, swab or sputum; samples 
indicate swabs if not otherwise stated). The respective Cq values of the individual samples (CDC-N1; QuickExtract RT-
qPCR or extracted RNA RT-qPCR as indicated) are shown above or below each sample. Colorimetric RT-LAMP using 
Phenol Red is shown for one sample set (first from top), again with inconclusive outcome. All reactions were performed 
in duplicates. The HNB color-reaction was read-out at 35 minutes unless indicated otherwise. Summary dotplots for 
every sample set are shown to the right; samples were classified as detected or not detected based on RT-LAMP 
outcome and plotted against their respective RT-qPCR determined Cq values.  
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Figure S4: Assessment of the bead enrichment procedure. 
A) Schematic depicting the workflow to asses bead recovery performance. Synthetic SARS-CoV-2 standard was diluted 
in HBSS:QuickExtract lysis buffer (1:1). 40 µl were subjected to magnetic bead enrichment, followed by elution of 
nucleic acids in 20 µl of RNase-free water by incubation at 63˚C for 5 min. 2 µl of the input (before enrichment) and 
the eluate (after bead enrichment) were analysed by 1-step RT-qPCR. B) RT-qPCR Cq values of different dilutions of 
synthetic SARS-CoV-2 standard before (black) and after bead enrichment (red). Duplicate experiments are shown. 
qPCR efficiency was calculated as 10^(-1/slope of the linear regression of datapoints). C) Calculated recovery (in %) 
after bead enrichment for the dilution series of synthetic SARS-CoV-2 RNA standard measured in B) per enrichment 
reaction. Replicate experiments are shown in black and green. 
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Figure S5: Pooled Covid-19 testing strategy using bead-LAMP. 
A) Performance of bead-LAMP on crude patient samples. The image (top) shows HNB end-point colorimetric readout 
and the heatmap (bottom) shows co-measured end-point relative fluorescence units (RFUs) of RT-LAMP on serially 
diluted patient samples in QuickExtract-prepared HeLa cell lysate, with or without prior bead enrichment. Cq values are 
estimated based on RT-qPCR measurement of the Cq value of the undiluted parental Covid-19 patient sample prior to 
bead enrichment. All reactions were performed in duplicates. B) RT-qPCR Cq values (CDC-N1) of gargle sample pools 
used in Fig 4H-J with the indicated fraction of Covid-19 positive gargle sample per pool. For the two large sample 
pools (pool of 1 in 96 and pool of 1 in 48), the 100 µl aliquot used for subsequent RT-LAMP and bead-LAMP was 
measured in addition. C) Readout of a real-time fluorescence RT-LAMP reaction of sample pools with indicated 
fraction of positive lysate without (left) and with (right) bead enrichment. RFU: relative fluorescent units. D) Schematic 
illustrating the pooled testing strategy. Eight pools mimicking different total patient sample numbers and different ratios 
of Covid-19-positive patient samples (0-100%) were generated from one Covid-19-positive QuickExtract patient 
sample (N1 RT-qPCR with Cq ~30) mixed at the indicated ratios with QuickExtract HeLa cell lysate at 20 cells/µl. E) 
Shown is the performance (measured as end-point relative fluorescence units (RFU)) of bead-LAMP (filled circles) 
compared to regular RT-LAMP (open circles) on the patient pools defined in D. ND = not detected within 60 minutes of 
RT-LAMP incubation. F) Images showing the endpoint HNB colorimetric readout of samples measured in E with or 
without prior bead enrichment. G) Bead-enrichment makes crude QuickExtract samples compatible with the pH-
sensitive Phenol Red based colorimetric readout of RT-LAMP.  Images showing the endpoint Phenol Red colorimetric 
readout (top) and the fluorescent readout (bottom) of two Covid-19 positive pools and one Covid-19 negative pool 
(qPCR negative) defined in D with (+) or without (-) prior bead enrichment. 
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Figure S6: Comparison of different Bst polymerases for RT-LAMP. 
A) Performance of Bst LF (blue curves) or Bst 2.0 (black curves) on crude Covid-19 patient sample (prepared in 
QuickExtract). Amplification curves indicate real-time fluorescence measurements of RT-LAMP reactions (E1 primer 
set; in duplicates) using SARS-CoV-2 positive (filled circles) or SARS-CoV-2 negative (open circles) patient samples 
as input. B)  Comparison of the ability of wildtype (Bst LF, blue) and engineered Bst polymerase (Bst 2.0, black) to 
incorporate dUTP during RT-LAMP on synthetic SARS-CoV-2 RNA standard. Reactions were either run under 
standard RT-LAMP conditions (-dUTP, filled circles), or supplemented with 0.7 mM dUTP, 0.7 mM dTTP and 1.4 mM 
of each dATP, dCTP, dGTP (open circles). Plotted is the ‘time to threshold’ as a measure of performance. C) LAMP 
performance (given as time to threshold in minutes) of indicated Bst DNA polymerase variants in the absence of a 
dedicated reverse transcriptase (-RTx) using diluted synthetic SARS-CoV-2 RNA (copies per reaction indicated) as 
template (related to Figure 6A). D) RT-LAMP real-time fluorescence measurements using RTx and Bst 2.0 in IsoAmp 
buffer I (left) versus Bst 3.0 alone in IsoAmp buffer II (right). N2 DETECTR was used as primer set for amplifying 
synthetic SARS-CoV-2 RNA standard (copy number per reaction is indicated; no target control (NTC): water). E) 
Shown is the collateral cleavage activity (measured as real-time fluorescent signal) by Cas12, with a crRNA targeting 
the N2 LAMP amplicon, upon addition of 2 µl of LAMP reactions from D) to 20 µl of Cas12 cleavage mix. F) (Left) 
End-point fluorescence values (after 60 minutes) of RT-LAMP reactions from D). (Right) Cas12-based detection of 
LAMP products from D) is indicated. 
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Figure S7: Comparison of different reverse transcriptases and Bst polymerases for RT-LAMP. 
A) Amplification curves (real-time fluorescent measurements; in triplicates) from RT-LAMP reactions shown in Figure 
6B. B) Amplification curves (real-time fluorescent measurements; in duplicates) from RT-LAMP reactions shown in 
Figure 6D. 
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Figure S8: Potential of RT-LAMP-based assays for clinical SARS-CoV-2 diagnostics. 
A) Hypothetical performance of RT-LAMP-based assays based on copy numbers of SARS-CoV-2 RNA (measured by 
RT-qPCR) in patient samples derived from nasopharyngeal swabs in 3 ml transport medium. Copy numbers per 3 ml 
swab were calculated from estimated copies per reaction measured by 1-step RT-qPCR using Cq 30 = 1000 copies/
reaction as reference (Figure S4 process control). Dashed lines indicate threshold detection levels for each procedure 
when considering 20 µl of original sample for RT-qPCR and RT-LAMP on extracted RNA (from 100 µl original sample 
eluted in 50 µl), 100 µl of original sample for bead-LAMP, and 1 µl of original sample for RT-LAMP and RT-qPCR on 
crude lysate. Patients were classified as infectious (red) if copies per swab were >1e6 (Wölfel et al., 2020). 
B) Hypothetical detection rates of RT-qPCR and various RT-LAMP-based assays with regards to infectivity based on 
the data shown in A). For bead-LAMP, detection rates considering maximal nucleic acid recovery rates (100%) and 
measured average nucleic acid recovery rates (77%) are shown. 
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